Natixis Advisors, L.P. Exact Sciences Corp Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$56.27 - $73.77 $387,587 - $508,127	-6,888 Reduced 9.1%	68,818 $4.75 Million
Q4 2023 Feb 06, 2024	SELL	$59.06 - $75.72 $139,972 - $179,456	-2,370 Reduced 3.04%	75,706 $5.6 Million
Q3 2023 Nov 13, 2023	SELL	$65.94 - $99.04 $73,457 - $110,330	-1,114 Reduced 1.41%	78,076 $5.33 Million
Q2 2023 Aug 15, 2023	SELL	$62.68 - $95.05 $90,384 - $137,062	-1,442 Reduced 1.79%	79,190 $7.44 Million
Q1 2023 May 11, 2023	BUY	$47.19 - $70.77 $244,680 - $366,942	5,185 Added 6.87%	80,632 $5.47 Million
Q4 2022 Jan 27, 2023	BUY	$30.35 - $53.15 $831,377 - $1.46 Million	27,393 Added 57.0%	75,447 $3.74 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $292,109 - $451,093	9,137 Added 23.48%	48,054 $1.56 Million
Q2 2022 Aug 12, 2022	SELL	$35.61 - $76.23 $223,702 - $478,876	-6,282 Reduced 13.9%	38,917 $1.53 Million
Q1 2022 May 12, 2022	SELL	$57.56 - $82.54 $257,005 - $368,541	-4,465 Reduced 8.99%	45,199 $3.16 Million
Q4 2021 Feb 08, 2022	BUY	$72.5 - $100.68 $7,032 - $9,765	97 Added 0.2%	49,664 $3.87 Million
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $951,671 - $1.31 Million	10,546 Added 27.03%	49,567 $4.73 Million
Q2 2021 Aug 12, 2021	BUY	$93.66 - $139.27 $1,779 - $2,646	19 Added 0.05%	39,021 $4.85 Million
Q1 2021 May 05, 2021	SELL	$116.57 - $155.01 $211,924 - $281,808	-1,818 Reduced 4.45%	39,002 $5.14 Million
Q4 2020 Feb 12, 2021	BUY	$99.61 - $142.12 $1.27 Million - $1.81 Million	12,747 Added 45.41%	40,820 $5.41 Million
Q3 2020 Nov 12, 2020	SELL	$72.92 - $102.01 $140,006 - $195,859	-1,920 Reduced 6.4%	28,073 $2.86 Million
Q2 2020 Aug 11, 2020	BUY	$55.75 - $92.75 $287,224 - $477,848	5,152 Added 20.74%	29,993 $2.61 Million
Q1 2020 Apr 27, 2020	BUY	$37.9 - $104.44 $146,180 - $402,825	3,857 Added 18.38%	24,841 $1.44 Million
Q4 2019 Feb 10, 2020	BUY	$77.66 - $99.74 $202,381 - $259,922	2,606 Added 14.18%	20,984 $1.94 Million
Q3 2019 Nov 12, 2019	SELL	$90.37 - $122.49 $13,103 - $17,761	-145 Reduced 0.78%	18,378 $1.66 Million
Q2 2019 Aug 12, 2019	BUY	$89.51 - $118.04 $17,633 - $23,253	197 Added 1.07%	18,523 $2.19 Million
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $76,297 - $118,791	1,231 Added 7.2%	18,326 $1.59 Million
Q4 2018 Feb 13, 2019	BUY	$56.04 - $82.66 $309,004 - $455,787	5,514 Added 47.61%	17,095 $1.08 Million
Q3 2018 Nov 13, 2018	BUY	$48.29 - $80.6 $559,246 - $933,428	11,581 New	11,581 $914,000

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

Vanguard Group Inc Valley Forge, PA

17.8M
Shares

$1.02 Billion
0.02% of portfolio
Capital World Investors Los Angeles, CA

15.8M
Shares

$911 Million
0.17% of portfolio
Wellington Management Group LLP Boston, MA

14.3M
Shares

$824 Million
0.18% of portfolio
Black Rock Inc. New York, NY

12.1M
Shares

$694 Million
0.01% of portfolio
State Street Corp Boston, MA

6.68M
Shares

$384 Million
0.02% of portfolio

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account